Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Importation Should Be Preemptive Tool During Shortages, Group Tells FDA

Executive Summary

The Greater New York Hospital Association, in a meeting with FDA Commissioner Margaret Hamburg, says the agency should be more proactive when considering importation of unapproved drugs to mitigate a shortage.

You may also be interested in...

Germany’s New Drug Register To Help Tackle Supply Shortages, But Larger EU Problem Looms

The new German drug register is designed to be a first step in tackling potential drug shortages on the domestic market, but it currently lacks effective solutions.

FDA Drug Shortage Staff Gets Higher Profile As New Reporting Requirements Begin

The 11-member staff CDER devotes to drug shortages is moving to the Office of the Center Director and will report to Deputy Director for Regulatory Programs Doug Throckmorton.

Economics Of Gaining Approval For Unapproved Phenylephrine Remains Question Mark

West-Ward could be the first to gain approval for phenylephrine in hypotension, but the drug’s widespread use as a stand-by medication during surgery could deter FDA enforcement against unapproved versions.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts